Hypercholesterolemia - Pipeline Review, H2 2014

Global Markets Direct
September 30, 2014
153 Pages - SKU: GMD5348073
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease
2/24/2015 | published by: MP Advisors
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease While targeting unmet needs in the treatment of hematological malignancies/ cancer through  |  read more...
USD 3,000
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019
2/18/2015 | published by: MarketsandMarkets
Pyrogen Testing Market by Product (Instruments, Services, Kits & Reagents), by Test (In Vitro, LAL, Rabbit Test), by Application (Pharmaceutical & Biotechnology Companies, Medical Devices, Other Applications) - Global Forecast to 2019 Pyrogen testing  |  read more...
USD 4,650
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market
1/28/2015 | published by: Frost & Sullivan
A Product and Pipeline Analysis of the Lung Cancer Therapeutics Market The estimated market size for lung cancer therapeutics in 2014 was $?? billion. There is increasing competition in this market, especially amongst  |  read more...
USD 5,000
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III  |  read more...
USD 2,000
Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Acute Heart Failure-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed  |  read more...
USD 2,000
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Dyslipidemia.  |  read more...
USD 2,000
Global Migraine Drugs Market 2015-2019
2/4/2015 | published by: TechNavio - Infiniti Research Ltd.
Global Migraine Drugs Market 2015-2019 About Migraine Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Given their hormonal  |  read more...
USD 3,000
Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015 DelveInsight’s, “Post-Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across  |  read more...
USD 2,000
Global Herpes Industry 2014 Market Research Report
1/20/2015 | published by: 9Dimen Research
2014 Global Herpes Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Herpes industry, focusing on the main regions (North America, Europe and Asia) and the  |  read more...
USD 2,850
Breast Cancer - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
Breast Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Breast  |  read more...
USD 2,500
 

SELECT A LICENSE

    Online Download  USD 2,000  
    Site License  USD 4,000  
    Global Site License  USD 6,000  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!